Long-term naltrexone treatment reduces the exaggerated insulin secretion in patients with polycystic ovary disease (Q72845082)

From Wikidata
Jump to navigation Jump to search
scientific article published on 01 August 1993
edit
Language Label Description Also known as
English
Long-term naltrexone treatment reduces the exaggerated insulin secretion in patients with polycystic ovary disease
scientific article published on 01 August 1993

    Statements

    Long-term naltrexone treatment reduces the exaggerated insulin secretion in patients with polycystic ovary disease (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit